Showing results (1-10 of 61) with videos related to
Sort By:
Pageof 7
Immunology|January 10, 2003
Mycobacterium bovis bacillus Calmette-Guérin-infected dendritic cells potently activate autologous T cells via a B7 and interleukin-12-dependent mechanismEleanor J Cheadle, Peter J Selby, Andrew M JacksonInfection and Immunity|January 25, 2005
Closely related mycobacterial strains demonstrate contrasting levels of efficacy as antitumor vaccines and are processed for major histocompatibility complex class I presentation by multiple routes in dendritic cellsEleanor J Cheadle, Dearbhaile O'Donnell, Peter J Selby, et al.Immunotherapy|September 4, 2013
Targeting T cells to tumor: exploiting the chimeric antibody receptorDavid E Gilham, Eleanor J CheadleCancers|May 4, 2026
The Tumour Immune Microenvironment as a Predictor of the Response to Neoadjuvant Therapy in Rectal CancerSreya Wadud, Eleanor J Cheadle, Paul A SuttonCancers|October 3, 2020
Understanding the Effects of Radiotherapy on the Tumour Immune Microenvironment to Identify Potential Prognostic and Predictive Biomarkers of Radiotherapy ResponseShuhui Cheng, Eleanor J Cheadle, Timothy M IllidgeBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 7, 2005
Toward personalized immunotherapy for non-Hodgkin lymphoma: targeting the idiotypic immunoglobulinAnne C Armstrong, Eleanor J Cheadle, Robert E HawkinsBritish Journal of Haematology|May 15, 2008
The combination of cyclophosphamide and human T cells genetically engineered to target CD19 can eradicate established B-cell lymphomaEleanor J Cheadle, David E Gilham, Robert E HawkinsExpert Opinion on Biological Therapy|September 6, 2014
Update on obinutuzumab in the treatment of B-cell malignanciesTim Illidge, Eleanor J Cheadle, Claire Donaghy, et al.Radiation Oncology (London, England)|November 5, 2020
Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinationsMadyson Colton, Eleanor J Cheadle, Jamie Honeychurch, et al.Pageof 7